ScholarIQanswers from OpenAlex & ORCID
Zoran Protrka
ResearcherPublications, citations & collaboration network
Zoran Protrka is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Zoran Protrka have?
ScholarIQindexed works
Zoran Protrka has 36 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Zoran Protrka have?
ScholarIQcitation count
Zoran Protrka has 105 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Zoran Protrka?
ScholarIQh-index
Zoran Protrka has an h-index of 6 in OpenAlex.
What is the i10-index of Zoran Protrka?
ScholarIQi10-index
Zoran Protrka has an i10-index of 4 in OpenAlex.
What is the ORCID of Zoran Protrka?
ScholarIQorcid
The ORCID for Zoran Protrka is on the source record.
What is the OpenAlex record for Zoran Protrka?
ScholarIQopenalex
The OpenAlex for Zoran Protrka is on the source record.
What are the most-cited papers on Zoran Protrka?
ScholarIQmost cited works
Evaluation of brivaracetam: a new drug to treat epilepsy
Jasmina Milovanović, Slobodan Јаnkovic, Ana V. Pejčić, Miloš N. Milosavljević, Valentina Opančina, Vesela Radonjić, Zoran Protrka, Marina Kostić
Gestational choriocarcinoma of the cervix.
Slobodanka Mitrović, Petar Arsenijević, Duško Kljakić, Janko Djurić, Miloš Milosavljević, Zoran Protrka, Radiša Vojinović
Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions
Zoran Protrka, Slobodan Arsenijević, Aleksandra Dimitrijević, Slobodanka Mitrović, Vesna Stanković, Miloš Milosavljević, Tatjana Kastratović, Janko Djurić
Cisplatin monotherapy with concurrent radiotherapy versus combination of cisplatin and 5-fluorouracil chemotherapy with concurrent radiotherapy in patients with locoregionally advanced cervical carcinoma.
Jasmina Nedović, Zoran Protrka, Srdjan Ninkovic, Slobodanka Mitrović, Radiša Vojinović, Jovica Glisic, Biljana Markovic-Filipovic, Bojan Milošević, Miodrag Peulić, Aleksandar Cvetković
Usefulness of human epididymis protein 4 in predicting optimal cytoreductive therapy in patients with advanced ovarian cancer.
Vesna Paunović, Zoran Protrka, Daniela Ardalić, Tomislav Paunovic